NASDAQ:CRSP | Insider Transactions — Page 7 | CRISPR Therapeutics AG

CRSP Insider Transactions — Page 7

620 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 601–620; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Versant Ophthalmic Affiliates I, L.P.TenPercentOwner2016-10-24Purchase602.0$14.0
Versant Venture Capital V (Canada), LPTenPercentOwner2016-10-24Purchase602.0$14.0
Versant Venture Capital IV, L.P.TenPercentOwner2016-10-24Purchase95,596.0$14.0
Versant Side Fund IV, L.P.TenPercentOwner2016-10-24Purchase95,596.0$14.0
Versant Affiliates Fund V, L.P.TenPercentOwner2016-10-24Purchase95,596.0$14.0
Versant Venture Capital V, L.P.TenPercentOwner2016-10-24Purchase95,596.0$14.0
Versant Ophthalmic Affiliates I, L.P.TenPercentOwner2016-10-24Purchase95,596.0$14.0
Versant Venture Capital V (Canada), LPTenPercentOwner2016-10-24Purchase95,596.0$14.0
Woiwode ThomasDirector2016-10-24Purchase4,583.0$14.0
Woiwode ThomasDirector2016-10-24Purchase60,219.0$14.0
Woiwode ThomasDirector2016-10-24Purchase602.0$14.0
Woiwode ThomasDirector2016-10-24Purchase95,596.0$14.0
Bolzon Bradley J PhDDirector2016-10-24Purchase4,583.0$14.0
Bolzon Bradley J PhDDirector2016-10-24Purchase60,219.0$14.0
Bolzon Bradley J PhDDirector2016-10-24Purchase602.0$14.0
Bolzon Bradley J PhDDirector2016-10-24Purchase95,596.0$14.0
CELGENE CORP /DE/TenPercentOwner2016-10-24Purchase800,150.0$14.0
CELGENE CORP /DE/TenPercentOwner2016-10-24Purchase800,150.0$14.0
George SimeonDirector2016-10-24Purchase66,500.0$14.0
GLAXOSMITHKLINE PLCTenPercentOwner2016-10-24Purchase66,500.0$14.0